chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Moderna COVID-19 Vaccine EUA Hot tingling on back of tongue and throat about 45 minutes after vaccine, racing heart (sustained high pulse 120 bpm), high blood pressure, unsteady when walking, a tad dizzy, very tired, fever 100.6 Ambulance called, listened to breathing (not abnormal), and did EEG (not abnormal). Released without being taken to hospital and advised to sleep it off.  It is day 3 and heart rate still slightly elevated, very fatigued (I have slept 35 of last 55 hours), low grade fever, muscle aches, bad headache
pt vaxed 5MAY92 & w/in 24 hrs pt exp an inject site react 8" x 5"; site was hot to the touch, itchy & purple & red in color; seen in ER dx cellulitis; no cultures taken; tx included ATB; seen in office 9NOV92 arm sl better; pt recovered;
1 OR 2 RED RAISED ERUPTIONS(.5 TO 1 cm) ON UPER LF ARM WITH IRRITATION AND ITCHING. TREATED /W/ DIPROLENE.2-19-90 2ND DOSE OF ENGERIX B ERUPTIONS LARGER NOW CRUSTY.2-22 TREATED /W/ KEFLEX FOR IMPETIGO.2-26 DIAG POSS ALLERG REACT TO HEP B.
Hands and feet swollen for three weeks.  Joints and /or tendons painful, but left hand pinky finger still swollen and extremely painful, Can not use finger because it no longer can close- since Covid19  Vaccination shot.( no longer can I play my violin). Went to my primary care doctor, 3/24/2021, who referred me to Doctor of Acting Chief of Hand Surgery, Medical Center- He administered a steroid shot into my finger on 03/29/2021.  No improvement- MRI scheduled on 04/20/2021.
Kinrix was incorrectly administered to 4 month old patient who had already received HIB vaccine.  Per CDC, doses were still considered valid and no revaccination needed.  No adverse events were reported day of when author spoke with patient's family or on 9/26/23 when FNP spoke with patient's family to check in.
10 x 6 cm area of erythema on left deltoid area developed, one day after patient received an Influenza A vaccine. Erythema is around and distal to injection site. No fever. No tenderness. No treatment required - observation. Of note last year patient also had similar reaction to the influenza vaccine but was thought to be cellulitis and was treated with antibiotics. (Mom states it was reported).
Information has been received from a physician concerning a 17 year old female with no specified pertinent medical history, who on 07-SEP-2007 was vaccinated with the first dose of GARDASIL, lot # 654510/0962F, and she was reported as fine.  Subsequently, sometime later on an unspecified date, the patient experienced seizures.  On 17-NOV-2007, the client received her second dose of GARDASIL, lot # 657006/01884, and she is still experiencing some sporadic seizures/epilepsy activity.  The patient is recovering and is being seen by a neurologist for follow-up.  Upon internal review, seizures were considered to be an other important medical event.  Additional information has been requested. 7/4/08 Vaccination record reveals patient received HPV #1, lot #0962F, on 5/29/2007; and HPV #2, lot #0188U, on 9/7/2007.  7/15/08 Reviewed hospital medical records of 11/17-11/20/2007. FINAL DX: Conversion disorder Records reveal patient experienced syncope, right arm shaking, postictal confusion.  Seen by PCP w/o treatment.  Presented to ER w/right arm/leg weakness & unable to get OOB.  On exam, c/o right temporal HA, RUE & RLE slightly weak w/decreased sensory.  Gait was normal.  Neuro & psych consults done.
Pain in arm; Itching; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm) and PRURITUS (Itching) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm) and PRURITUS (Itching). At the time of the report, PAIN IN EXTREMITY (Pain in arm) and PRURITUS (Itching) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
I was 4 weeks pregnant when I received the vaccine and had a miscarriage at 5 weeks 3 days.   I had one healthy pregnancy to 41 weeks in 2019 and I was and still am breastfeeding.
Left arm is blushed and hot on injection site; Left arm is blushed and hot on injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE DISCOLOURATION (Left arm is blushed and hot on injection site) and VACCINATION SITE WARMTH (Left arm is blushed and hot on injection site) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.  The patient's past medical history included No adverse event (No medical history reported.).    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced INJECTION SITE DISCOLOURATION (Left arm is blushed and hot on injection site) and VACCINATION SITE WARMTH (Left arm is blushed and hot on injection site). At the time of the report, INJECTION SITE DISCOLOURATION (Left arm is blushed and hot on injection site) and VACCINATION SITE WARMTH (Left arm is blushed and hot on injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant products use was not provided by the reporter.   Treatment for the event was not reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 16-Feb-2021 and was forwarded to Moderna on 16-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE DISCOLOURATION (Left arm is blushed and hot on injection site) and VACCINATION SITE WARMTH (Left arm is blushed and hot on injection site) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.  The patient's past medical history included No adverse event (No medical history reported.).    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced INJECTION SITE DISCOLOURATION (Left arm is blushed and hot on injection site) and VACCINATION SITE WARMTH (Left arm is blushed and hot on injection site). At the time of the report, INJECTION SITE DISCOLOURATION (Left arm is blushed and hot on injection site) and VACCINATION SITE WARMTH (Left arm is blushed and hot on injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant products use was not provided by the reporter.   Treatment for the event was not reported.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided. On 09-JAN-2017, the patient was vaccinated with improperly stored dose of PROQUAD lot # M029598, expiration date 10-DEC-2017, albumin status recombinant human albumin (rHA) (dose, route and site of administration were not reported). No adverse effects reported. Administered vaccine experienced the temperature excursion of -14.4 Celsius degrees for 54 minutes. There was no previous temperature excursion reported. Data logger was involved. This is one of several cases received from the same reporter. Additional information is not expected, all information has already been obtained. Sender's Comments: US-009507513-1611USA004113: US-009507513-1611USA011831: US-009507513-1705USA009742.
Systemic: Body Aches Generalized-Medium, Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Weakness-Medium, Additional Details: Patient reports weakness, leg muscle tightness, difficulty walking, and dizziness.  Started post vaccine and has continued.  Patient was advised to go to local urgent care for examination on 6/9.
Narrative: COVID infection following COVID vaccine series 03/08, Pfizer, dose #1 03/27, Pfizer, dose #2 03/25 COVID swab, result: not detected 08/06 COVID swab, result: not detected 12/22 SARS-COV-2 Variant Sequencing: pending 12/22 COVID swab, result: detected 12/22 pt cc: exposure: unknown
3/31/21 To er for eval of dizziness. States she was at the hairdresser when she became very dizzy and had to lay  In the floor, was nauseated but no vomiting. Incident happened approximately 10am.
On March 18th I received the Moderna Vaccine #2 at approximately 11 am. A few days later I started to feel tired. Then as time progressed, I lost my libido, sex drive, this vaccine made my vertigo worse...I am dizzy...My heart rate went down 10 bpm and I feel like I have a virus in me. The longer I sleep the worse it feels...If I had to go back and do this again, the way I feel, I WOULD NOT. This vaccine messed up my RNA and the Cytosine's are making me feel ill and not 100%.
Injection site has tenderness and a little swelling in the same arm of the injection, swelling and redness continuing a week after the shot has been given.  It is super itchy around the injection site as well and I feel like my entire left side is swollen (arm and leg all the way to my ankle feels swollen)
Headache, nausea, dizziness/lightheadedness, blurred vision, muscle and body aches, fever 102.4, increased heart rate and palpitations, shortness of breath.
cannot remember if they received the first dose of the Shingrix vaccine; This case was reported by a consumer via  interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The age at vaccination was not applicable for this report. The patient cannot remember if they have received the 1st dose of vaccine and was asking could they start over with the series, which led to incomplete course of vaccination. No further information was reported. Follow up was not possible as no contact details were provided.
Body is shaking; heart was jumping out of her chest; she was very uncomfortable for 8 to 10 hours; not able to get back to sleep at all, she was up the entire night; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 68-year-old female patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TREMOR (non-serious) with onset Mar2021, outcome "unknown", described as "body is shaking"; HEART RATE INCREASED (non-serious) with onset Mar2021, outcome "unknown", described as "heart was jumping out of her chest"; FEELING ABNORMAL (non-serious) with onset Mar2021, outcome "recovered", described as "she was very uncomfortable for 8 to 10 hours"; INSOMNIA (non-serious) with onset Mar2021, outcome "recovered", described as "not able to get back to sleep at all, she was up the entire night". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Reporter stated she was interested in getting the Pfizer-BioNTech Covid19 Vaccine booster dose, but she had a very bad reaction from the 1st and 2nd dose that she had back in March. Reporter stated, 12-hrs after her 1st dose, she woke up out of a sound sleep with her whole body is shaking, her heart was jumping out of her chest, she was very uncomfortable for 8 to 10 hours and was not able to get back to sleep at all, she was up the entire night, and it was worse on the 2nd dose. Reporter stated wants to know if this has been reported before.  Follow-up attempts completed. No further information is expected.
Palpitations; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Palpitations) and HEADACHE (Headaches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (Palpitations) and HEADACHE (Headaches). At the time of the report, PALPITATIONS (Palpitations) and HEADACHE (Headaches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medical information were reported. No treatment information was reported.  Company comment: Very limited information regarding these events has been provided at this time.   This case was linked to MOD-2021-295925 (Patient Link).; Sender's Comments: Very limited information regarding these events has been provided at this time.
Patient complaint dizziness and shortness of breath 5 minutes after injection. Then she recovered 5 seconds later. We checked her pulse and BP and checked her vital sign after 911 arrived. OK.
Twitching of injection site with mild dull pain.  Upper arm could be visibly seen convulsing for several minutes.  I've had many shots and NEVER had any similar side-effects.  Recurred throughout day.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old male patient received BNT162b2 (BNT162B2), on 10Oct2020 at 10:00 as dose 3 (booster), single (Lot number: FF2593) at the age of 64 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: VALSARTAN. Past drug history included: Known alergies: amantadine, reaction(s): "Known alergies: amantadine". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: indication: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course:Reported Treatment of COVID-19 with drug Paxlovid with start date 10Jul2022 and stop date 14Jul2022.  No follow-up attempts are needed. No further information is expected.
Information has been received from a pharmacist concerning two patients of unknown age and gender. The pharmacist reported that on unspecified dates two patients were vaccinated with ZOSTAVAX and on unspecified dates they experienced shingles. The outcome of shingles is unknown. Additional information is not expected.
Patient came in to report several adverse reactions after vaccine administration. She stated she was in good health condition prior to vaccine and started having problems soon after. On the day of the vaccine she felt fine but the day after she started having pain on her feet. She mentioned that went away after 3 days. Four days after the vaccine she began experiencing nausea/vomiting, hot flashes, dizziness which required ER visit. The day of the administration, she was given QR code to report side effects but she couldn't report it. RPh provided VAERS information so she can report it as well. ER did not think it was related to vaccine. Patient did mention how expensive medical treatment was and that she continues to have foot/ankle problem.
Approximately 5 minutes after vaccination, patient became diaphoretic and warm/flushed.  Complained of nausea and had one episode of emesis.  Patient given 50mg of diphenhydramine orally.
This spontaneous report as received from a registered nurse and refers to an unspecified number of patients of unknown ages and genders. The patients' pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On an unknown dates, the patients were vaccinated with improperly stored M-M-R II, (dose number, frequency, route, anatomical location, lot number and expiration date were not reported), for prophylaxis. On 19-DEC-2016 the vaccines experienced a temperature excursion of 29.8 Fahrenheit Degrees for 30 minutes, and, on 03-APR-2017 experienced a temperature excursion of 49 Fahrenheit Degrees for 15 minutes. The digital data logger was involved. No side effects were reported by the reporter. Concomitant therapies included sterile diluent, however, the registered nurse did not provide any lot number or expiration date for the properly stored sterile diluent.  This is one of several reports from the same reporter. Additional information has been requested.; Sender's Comments:  US-009507513-1704USA012148: US-009507513-1704USA011906: US-009507513-1704USA012147:
Patient was given wrong dosing of the vaccine. She was given 0.3ml instead 0.2ml.
12 hours post woke w tremors, freezing cold, nausea, high heart rate of 150, and temp of 103.6. Took ibuprofen and zofran. Fever broke by 7 am, nausea improved by noon. Tremors stopped w fever break.  Arm id red in 4 inch circle at injection. Itchy but tender. Felt no fatigue after a full day. Sent pcp a message to let her know. She followed up w message.
This medically confirmed spontaneous report (initial receipt 28-OCT-2014) concerns a 34 year old male patient. On 26-OCT-2014, AFLURIA underwent temperature excursion at 50 degree Fahrenheit. On 27-OCT-2014, AFLURIA again had temperature excursion at 50 degree Fahrenheit for undetermined amount of time. On 27-OCT-2014, the patient received temperature excursion AFLURIA (batch number: T50507) via intramuscular route at 0.5 ml.  Outcome was reported as unknown. Reporter's comments: The reporter assessed the event as non-serious.
Delayed hypersensitivity; This is a spontaneous report from a contactable pharmacist. A patient of unspecified age and gender received pneumococcal 13-valent conjugated vaccine (diphtheria crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced delayed hypersensitivity reaction to pneumococcal 13-valent conjugated vaccine (diphtheria crm197 protein). She was thinking it was related to the CRM protein. The outcome of the event was unknown.  Information on the batch number has been requested.
PT C/O THROAT SWELLING, LINGUAL NUMBNESS, AND A METALLIC TASTE. PT WAS GIVEN BENADRYL 50 MG PO. P T SYMPTOMS RESOLVED. 02 97% BP 100/62 HR 75
Shoulder pain started at approximately 4 o'clock in the afternoon.  Pain got progressively worse.  Pain is at the top front of the shoulder.  Limited mobility.  It arm hangs down with no motion, there is no pain.  Any slight movement emanating from the shoulder causes intense pain.
Information has been received from a pharmacist concerning his daughter, with no known allergies, who was vaccinated with MMR (lot # not reported). The pharmacist reported that his daughter, who at the time of this report, was 22 years old, and developmentally delayed, was vaccinated as a child and experienced an adverse event. Post vaccination, the patient developed a fever of 104 or higher. Unspecified medical attention was sought and the patient was treated with acetaminophen. Subsequently, the patient recovered from the fever (date not specified). It was unknown if the patient recovered from developmental delay. There was no product quality complaint involved. Upon internal medical review, developmental delay and fever of 104 or higher were considered to be other important medical events (OMIC). Additional information has been requested.
Gave out occasional high pitched scream - unusual fussy following Wed 30JAN woke up w/a barking cough, drooling & trouble breathing.
Dizziness and nausea.  Numbness of arms, legs and head, shaking, fainting.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient. A 45-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 29Mar2021 as dose 1, single (Lot number: EN6207), in left arm, on 27Apr2021 as dose 2, single (Lot number: EW0172), in left arm and on 18Dec2021 as dose 3 (booster), single (Lot number: 3310308A) at the age of 45 years, in left arm for Covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "known allergies: sulfa drugs" (unspecified if ongoing), notes: known allergies: sulfa drugs. Concomitant medication(s) included: Amlodipine Besylate; Montelukast Sodium; Cetirizine Hydrochloride. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), all with latency 4 months 11 days after the suspect product(s) administration, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: The patient had received Paxlovid on 29Apr2022 for treatment of COVID-19 and stop on 03May2022. Other medication in 2weeks brand was Berkley Jensen.